Results 131 to 140 of about 17,610 (263)

The Number of Newly Dispensed Hypnotic Drugs During the First COVID‐19 Lockdown Period in The Netherlands

open access: yesJournal of Sleep Research, Volume 35, Issue 2, April 2026.
ABSTRACT The 2019 coronavirus (COVID‐19) pandemic and associated lockdowns significantly disrupted healthcare systems, including access to pharmacological treatments such as sleep medication. This study investigated the number of first‐time dispensed hypnotic drugs during the first COVID‐19 lockdown in the Netherlands, using data from the Dutch ...
Dana M. Dijkgraaf   +5 more
wiley   +1 more source

Longitudinal association between sleep and Alzheimer's pathology

open access: yesAlzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract INTRODUCTION Since sleep disturbance is a modifiable risk factor for Alzheimer's disease (AD), we tested associations between sleep and AD pathology in cognitively unimpaired (CU) persons. METHODS We included 223 participants from the PREVENT‐AD cohort with self‐reported measures of sleep, objective actigraphy measures of sleep, and positron ...
Bery Mohammediyan   +13 more
wiley   +1 more source

The neuromodulatory fragility hypothesis of Alzheimer's disease pathogenesis

open access: yesAlzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract Sporadic Alzheimer's disease (AD) is associated with numerous risk factors, yet its precise cause remains unclear. Here, we describe a novel framework for AD pathogenesis, whereby diverse risk factors converge on neuromodulatory subcortical systems to confer AD risk or resilience.
Alfie Wearn   +4 more
wiley   +1 more source

Sex differences in neuromodulatory subcortical systems and their implications for Alzheimer's disease

open access: yesAlzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract Neuromodulatory subcortical systems (NSSs) are uniquely susceptible to dementia‐related pathology, leading to frequent molecular and behavioral impairments associated with altered function of these nuclei. Some of these systems display clear sex‐specific cytoarchitecture and signaling leading to distinct physiology and behavioral outputs in ...
Rosaria J. Rae   +53 more
wiley   +1 more source

A prolaktin-releasing peptid szerepének vizsgálata a központi idegrendszerben = Role of prolactin-releasing peptide in the central nervous system [PDF]

open access: yes, 2009
A prolaktin-releasing peptid (PrRP) számos, központi idegrendszeri funkcióját tanulmányoztuk. A tejelválasztásban a PrRP-t nem találtuk fontosnak. Krónikus, de nem akut stressz után a PrRP expresszió megnőtt, az adaptáció során megváltozott szabályozási ...
Tóth, Zsuzsanna   +2 more
core  

Wake‐promoting neuromodulators in Alzheimer's disease: Implications for sleep and brain clearance

open access: yesAlzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract Neuromodulatory subcortical systems (NSS) regulate arousal, cognition, and sleep–wake transitions through widespread influence on cortical and subcortical networks. Increasing evidence links dysfunction of these systems to the pathogenesis of Alzheimer's disease (AD). Degeneration and dysregulation of NSS occurs during the preclinical phase of
Taylor J. Pedersen   +7 more
wiley   +1 more source

The role of orexin A in the pathogenesis of ischaemic stroke at high altitude

open access: yesExperimental Physiology
Orexin offers protection against cerebral ischaemia–reperfusion injury, with high altitude playing a key role in modulating its expression. This study aimed to investigate the effect of high altitude on orexin expression and its pathophysiological ...
Minxia Zhu   +7 more
doaj   +1 more source

Glymphatic System Dysfunction in Central Nervous System Diseases

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 3, March 2026.
Glymphatic Dysfunction in Neurological Disorders: The glymphatic system is a brain‐wide clearance system that removes neurotoxic waste via AQP4‐mediated CSF‐ISF exchange. Dysfunction through AQP4 mislocalization, BBB injury, and inflammation annihilates clearance and causes acute (stroke, TBI) and chronic disease.
Anwar Zahran   +14 more
wiley   +1 more source

Relationship Between Cognitive Impairments and Serum Orexin Levels in Epilepsy Patients

open access: yesArchives of Epilepsy
Objective: Recent studies on neurodegenerative diseases have indicated that Orexin A plays a role in cognitive impairment. Furthermore, animal studies have demonstrated that Orexin A enhances synaptic plasticity in the hippocampus.
Zeliha Yücel   +4 more
doaj   +1 more source

Insomnia‐Driven Hippocampal Atrophy: Evidence From Bidirectional Mendelian Randomization

open access: yesHealth Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background Observational studies link insomnia to hippocampal atrophy, yet causal inference remains limited by confounding and reverse causality. While Mendelian randomization (MR) studies have explored sleep‐brain associations, bidirectional causality between insomnia and hippocampal subfield volumes remains unaddressed.
Dandan Han   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy